All News

Educated Patient® Metastatic Breast Cancer Summit Management of Triple Negative Disease Presentation: November 12, 2022

November 25th 2022

Watch Dr. Neelima Vidula, from Massachusetts General Hospital, discuss the management of triple-negative disease during the CURE Educated Patient Metastatic Breast Cancer Summit.

Writing Thank You Letters to My Oncology Team Helped Me Feel Grounded and Grateful

November 24th 2022

After being diagnosed with breast cancer, I wrote thank you letters to my oncology care team which, to my surprise, helped put me at ease.

Educated Patient® Metastatic Breast Cancer Summit: November 12, 2022

November 24th 2022

Watch Dr. Arielle J. Medford, from Dana-Farber Cancer Institute, discuss the management of HER2-positive disease during the CURE® Educated Patient® Metastatic Breast Cancer Summit.

Evaluating Existing and Future Surgical Options for Early-Stage Lung Cancer

November 23rd 2022

As part of its “Speaking Out” video series, Dr. Peter Baik, on behalf of Cancer Treatment Centers of America, discussed how far the space has come with surgical advances, and where it is headed, in treating early-stage lung cancer.

‘Time is of the Essence’ in Decision-Making for Early-Stage Lung Cancer

November 23rd 2022

As part of its “Speaking Out” video series, Dr. Peter Baik, on behalf of Cancer Treatment Centers of America, discussed the importance of timing and decision-making of treatment in early-stage lung cancer.

Expert Addresses Disparities in Lung Cancer Screening, What More Can Be Done

November 23rd 2022

As part of its “Speaking Out” video series, Dr. Peter Baik, on behalf of Cancer Treatment Centers of America, discussed disparities seen in lung cancer screening and what more can be done.

FDA to Expedite Review of Novel Non-Hodgkin Lymphoma Drug

November 23rd 2022

The Food and Drug Administration granted a priority review to epcoritamab for certain patients with large B-cell lymphoma, an aggressive type of blood cancer.

Cancer Survivorship Superstitions: Can a Delayed Mammogram Be Catastrophic?

November 23rd 2022

A routine can feel so comfortable that change is hard. So, when my annual mammogram and cancer checkup was delayed, I tried hard not to sweat the small stuff.

'A Village of People’ May Help Cancer Caregivers Balance Everyday Life

November 23rd 2022

A woman whose husband was diagnosed with ocular melanoma at 28 years old opens up about her experiences navigating the cancer world and her search for a supportive community.

Educated Patient® Metastatic Breast Cancer Summit HR-Positive Disease Panel: November 12, 2022

November 23rd 2022

Watch Dr. Aditya Bardia, Dr. Seth A. Wander and Dr. Laura M. Spring answer questions about HR-positive disease during the CURE Educated Patient Metastatic Breast Cancer Summit.

FDA Approval of Elahere Represents a ‘Step Forward’ for Platinum-Resistant Ovarian Cancer Subset

November 22nd 2022

One expert said that the FDA approval of the antibody-drug conjugate Elahere represents a new treatment option for patients with folate receptor alpha-positive, platinum resistant ovarian cancer.

High Sugar Intake May Lead to Premature Aging in Childhood Cancer Survivors

November 22nd 2022

Childhood cancer survivors who had high daily sugar intake — especially when it came to sweetened beverages — had an increased risk of premature aging-related health complications, according to recent research.

Preparing For a Season of Thanksgiving as a Cancer Survivor

November 22nd 2022

Thanksgiving can be a stressful time for those with cancer, but it doesn’t have to be. I learned that it can also be a time filled with love and joy.

You Are Not Alone: The Sarcoma Alliance as a Patient Advocate

November 22nd 2022

A nonprofit organization aims to connect patients, caregivers and loved ones affected by sarcoma while educating those about the rare cancer.

Educated Patient® Metastatic Breast Cancer Summit Overview of Management of Hormone Receptor-positive Breast Cancer: Third Line and Beyond Presentation: November 12, 2022

November 22nd 2022

Watch Dr. Laura M. Spring, from Massachusetts General Hospital in Boston, discuss treatment in third line and beyond for hormone receptor-positive breast cancer, during the CURE® Educated Patient® Metastatic Breast Cancer Summit.

Finding Support During a Multiple Myeloma Diagnosis

November 21st 2022

As a part of its “Speaking Out” video series, on behalf of the International Myeloma Foundation, CURE® spoke with their vice president of support, Robin Tuohy about the importance of support for patients with multiple myeloma, and their caregivers.

The Basics of Clinical Trials for Patients with Multiple Myeloma

November 21st 2022

As a part of its “Speaking Out” video series, on behalf of the International Myeloma Foundation, CURE® spoke with their chief medical officer, Dr. Joseph Mikhael about clinical trials for patients with multiple myeloma.

Spotlighting Disparities in Multiple Myeloma

November 21st 2022

As a part of its “Speaking Out” video series, on behalf of the International Myeloma Foundation, CURE® spoke with their chief medical officer, Dr. Joseph Mikhael about disparities in the multiple myeloma space.

Treating, Monitoring and Understanding Myeloma Precursors, MGUS and Smoldering Myeloma

November 21st 2022

As a part of its “Speaking Out” video series, on behalf of the International Myeloma Foundation, CURE® spoke with their chief medical officer, Dr. Joseph Mikhael about the precursors to multiple myeloma, MGUS and smoldering myeloma.

Managing the Risk of Infection for Patients with Multiple Myeloma

November 21st 2022

As a part of its “Speaking Out” video series, on behalf of the International Myeloma Foundation, CURE® spoke with their chief medical officer, Dr. Joseph Mikhael about the risk of infection for patients with multiple myeloma.

Here’s How the Thanksgiving Plans of Cancer Survivors and Caregivers Are Being Affected by Cancer and COVID-19

November 21st 2022

CURE® surveyed its audience to see if cancer and the COVID-19 virus are changing their Thanksgiving plans. Here’s what they had to say.

Dealing With Delirium: My Experience With Cancer Painkillers as a Recovering Addict

November 21st 2022

As a recovering addict, I was nervous about the painkillers that would come alongside my cancer treatment, but I soon learned that they would be needed.

CAR-T Cell Therapy Demonstrates Similar Survival Across Socioeconomic Status in Children With Blood Cancer

November 21st 2022

Though remission rates for children who underwent CAR-T cell therapy did not differ based on socioeconomic status, accessibility gaps remain.

Educated Patient® Metastatic Breast Cancer Summit Overview of Management of Hormone Receptor-positive Breast Cancer Presentation: November 12, 2022

November 21st 2022

Watch Dr. Seth A. Wander, from Massachusetts General Hospital in Boston, discuss the first- and second-line treatment of hormone receptor-positive breast cancer, during the CURE® Educated Patient® Metastatic Breast Cancer Summit.

The 'Good' Cancer Does Not Exist

November 19th 2022

Think twice before telling me that there is a "good" type of cancer or that I should "just be lucky my daughter is still alive."

Libtayo’s Approval Part of the ‘Renaissance’ of Lung Cancer Advancements

November 18th 2022

The recent FDA approval of Libtayo for advanced non-small cell lung cancer added yet another option for the treatment of patients with the disease.

With Cancer, Small Gestures Count the Most

November 18th 2022

When my wife surprised me with a prostate cancer awareness T-shirt, I realized that those small gestures matter the most.

‘Star Trek’ Actors Team Up for Cancer Research, Michelle Obama Meets a Sarcoma Survivor and More

November 18th 2022

From “Star Trek” actors supporting the Pancreatic Cancer Action Network to Michelle Obama meeting with a sarcoma survivor and an update on Jane Fonda’s cancer, here’s what’s happening in the cancer space this week.

Novel Drug-Chemo Combination Improves Outcomes for Advanced Gastric Cancers

November 18th 2022

Zolbetuximab plus the chemotherapy regimen mFOLFOX6 improved progression-free survival and overall survival in certain patients with unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.

Advances in Sarcoma Treatment and Future Directions

November 17th 2022

An expert writes about his experience as a sarcoma medical oncologist and how the field may progress with several therapies in the pipeline.